Logo image
Orotic acid improves left ventricular recovery four days after heterotopic transplantation
Journal article   Open access   Peer reviewed

Orotic acid improves left ventricular recovery four days after heterotopic transplantation

Thomas Yeh, Ivan M. Rebeyka, Emma R. Jakoi, Danna E. Johnson, Rebecca J. Dignan, Cornelius M. Dyke and Andrew S. Wechsler
The Annals of thoracic surgery, v 58(2), pp 409-415
Aug 1994
PMID: 8067840
url
https://doi.org/10.1016/0003-4975(94)92216-0View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

Orotic acid accelerates compensatory myocardial hypertrophy after regional ischemia and improves left ventricular function acutely after global ischemia. In this study, the effect of orotic acid on left ventricular function was investigated 4 days after global ischemia (75 minutes, 21 °C) using heterotopically transplanted rabbit hearts (n = 18). Experimental animals received daily 100-mg/kg doses of intraperitoneally administered orotic acid, starting 1 day before transplantation, and showed a threefold increase in the serum level of orotic acid by 4 days. After 1 hour of reperfusion, the developed pressure was equally depressed in both the control and experimental groups; however, 4 days later, the developed pressure in control animals was decreased by 3 ± 3 mm Hg (versus the developed pressure measured at 1 hour) while the developed pressure in experimental animals was significantly increased by 25 ± 8 mm Hg. Heterotopically transplanted hearts manifested diminished systolic function (stemming from ischemia and unloading) as well as decreased expression of adult myosin. Because orotic acid has been observed to produce an increase in protein synthesis in other models, we investigated whether this improvement in systolic function resulted from an orotic acid-mediated augmentation (or preservation) of normal adult myosin expression. Both orotic acid-treated and untreated hearts manifested decreased expression of the β-myosin heavy chain protein and steady-state messenger RNA levels. Because function improved with decreased β-myosin heavy chain expression, an alternate mechanism underlying orotic acid-mediated improvement in function is implicated. Nevertheless, orotic acid may be a therapeutic agent facilitating long-term recovery from global ischemia.

Metrics

10 Record Views
10 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Cardiac & Cardiovascular Systems
Respiratory System
Surgery
Logo image